Researchers at Rensselaer Polytechnic Institute and Albany Medical Center are working together to develop three-dimensional bioprinting and imaging techniques that will generate and analyze tumor models in the laboratory, with the goal of accelerating the development and optimization of personalized anti-cancer drugs.

Michael Bramson, a 1st year PhD student in the Corr lab, was on one of three winning teams at the 2nd annual Mount Sinai Health Hackathon, and his team was awarded $2500 for their innovative platform Streamline, a web-based service designed to use natural language processing in assisting researchers write clinical trial applications and protocols